ZA986074B - Immunogenic LHRH compositions and methods relating thereto - Google Patents
Immunogenic LHRH compositions and methods relating theretoInfo
- Publication number
- ZA986074B ZA986074B ZA986074A ZA986074A ZA986074B ZA 986074 B ZA986074 B ZA 986074B ZA 986074 A ZA986074 A ZA 986074A ZA 986074 A ZA986074 A ZA 986074A ZA 986074 B ZA986074 B ZA 986074B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods relating
- immunogenic lhrh
- lhrh compositions
- immunogenic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO7768A AUPO776897A0 (en) | 1997-07-09 | 1997-07-09 | A method of achieving production gains in livestock and agents useful for same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA986074B true ZA986074B (en) | 1999-03-16 |
Family
ID=3802056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA986074A ZA986074B (en) | 1997-07-09 | 1998-09-07 | Immunogenic LHRH compositions and methods relating thereto |
Country Status (19)
| Country | Link |
|---|---|
| US (6) | US7534441B2 (xx) |
| EP (4) | EP2191839A3 (xx) |
| JP (3) | JP5116916B2 (xx) |
| KR (2) | KR100680631B1 (xx) |
| AT (1) | ATE458493T1 (xx) |
| AU (2) | AUPO776897A0 (xx) |
| CA (1) | CA2294865C (xx) |
| CY (2) | CY1109968T1 (xx) |
| DE (2) | DE69841521D1 (xx) |
| DK (1) | DK1007084T3 (xx) |
| ES (1) | ES2339308T3 (xx) |
| FR (2) | FR10C0035I2 (xx) |
| LU (1) | LU91711I2 (xx) |
| NZ (1) | NZ502080A (xx) |
| PL (1) | PL200495B1 (xx) |
| PT (1) | PT1007084E (xx) |
| TW (1) | TWI235666B (xx) |
| WO (1) | WO1999002180A1 (xx) |
| ZA (1) | ZA986074B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO776897A0 (en) | 1997-07-09 | 1997-07-31 | Csl Limited | A method of achieving production gains in livestock and agents useful for same |
| AUPP807399A0 (en) * | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
| ES2233284T3 (es) | 1999-02-17 | 2005-06-16 | Pfizer Products Inc. | Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune. |
| US8088734B2 (en) * | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
| WO2006027300A2 (en) * | 2004-08-04 | 2006-03-16 | Cytos Biotechnology Ag | Carrier conjugates of gnrh-peptides |
| WO2006129162A2 (en) * | 2005-06-01 | 2006-12-07 | Pfizer Products Inc. | Vaccine compositions and methods for the treatment of urinary incontinence |
| WO2008110912A1 (en) * | 2007-03-14 | 2008-09-18 | Pfizer Inc. | Fertility regulation in horses |
| CN104854093B (zh) | 2012-12-03 | 2016-10-12 | 辉瑞大药厂 | 新的选择性雄激素受体调节剂 |
| KR101918381B1 (ko) * | 2017-01-11 | 2018-11-13 | 이경민 | 칠보 공예품을 제조하는 방법과 이에 의하여 제조되는 칠보 공예품 |
| KR102477054B1 (ko) * | 2020-03-24 | 2022-12-14 | 주식회사 바이오앱 | 웅취 제거용 재조합 단백질 및 이를 포함하는 백신 조성물 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3963691A (en) * | 1974-10-07 | 1976-06-15 | Merck & Co., Inc. | Synthetic antigens of luteinizing hormone releasing hormone |
| DE3411224A1 (de) * | 1984-03-27 | 1985-10-10 | Hoechst Ag, 6230 Frankfurt | Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren |
| NZ220932A (en) * | 1986-07-03 | 1990-05-28 | Victoria State | Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying |
| NZ221306A (en) * | 1986-08-15 | 1990-02-26 | Commw Scient Ind Res Org | 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof |
| WO1988005308A1 (en) * | 1987-01-14 | 1988-07-28 | Commonwealth Scientific And Industrial Research Or | Anti reproductive hormone |
| GB2228262B (en) * | 1989-01-25 | 1992-10-07 | Nat Inst Immunology | Antigenic derivative of gnrh |
| WO1990009799A1 (en) * | 1989-02-23 | 1990-09-07 | Colorado State University Research Foundation | GnRH ANALOGS FOR DESTROYING GONADOTROPHS |
| NL8900726A (nl) | 1989-03-23 | 1990-10-16 | Stichting Centr Diergeneeskund | Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens. |
| US5138034A (en) * | 1989-07-12 | 1992-08-11 | The Green Cross Corporation | Method of fractionating plasma proteins |
| EP0446313B1 (en) * | 1989-08-25 | 1996-07-31 | Biotechnology Australia Pty. Ltd. | Fusion proteins comprising TraTp and at least one LHRH analogue |
| US5324512A (en) * | 1990-12-26 | 1994-06-28 | The Population Council | [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses |
| PT501882E (pt) * | 1991-03-01 | 2000-12-29 | Merial Sas | Processo de imunoneutralizacao anti-lhrm de animais domesticos machos nao castrados e peptido para esse fim |
| ATE191147T1 (de) * | 1991-07-26 | 2000-04-15 | Commw Scient Ind Res Org | System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung |
| US5837268A (en) | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| ZA934199B (en) * | 1992-06-18 | 1994-01-10 | Akzo Nv | Carrier system against gnrh |
| US5614487A (en) * | 1993-05-28 | 1997-03-25 | Genentech, Inc. | Sustained release pharmaceutical composition |
| US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| USRE39048E1 (en) * | 1995-06-07 | 2006-03-28 | Pepscan Systems B.V. | Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine |
| DK0832107T3 (da) | 1995-06-07 | 2001-11-19 | Dlo Inst Voor Dierhouderij En | Forbedret peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af dyr mod hormonet LHRH samt analoge af LHRH-tandempeptid-gentagelsespeptidet og deres andvendelse som vaccine |
| WO1997015316A1 (en) | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | Conjugates of gonadotropin releasing hormone |
| AUPO776897A0 (en) * | 1997-07-09 | 1997-07-31 | Csl Limited | A method of achieving production gains in livestock and agents useful for same |
| US6013770A (en) * | 1997-07-21 | 2000-01-11 | Washington State University | Chimeric contraceptive vaccines |
-
1997
- 1997-07-09 AU AUPO7768A patent/AUPO776897A0/en not_active Abandoned
-
1998
- 1998-07-09 AT AT98931835T patent/ATE458493T1/de active
- 1998-07-09 EP EP10154397A patent/EP2191839A3/en not_active Withdrawn
- 1998-07-09 TW TW087111118A patent/TWI235666B/zh not_active IP Right Cessation
- 1998-07-09 WO PCT/AU1998/000532 patent/WO1999002180A1/en active IP Right Grant
- 1998-07-09 JP JP2000501770A patent/JP5116916B2/ja not_active Expired - Lifetime
- 1998-07-09 ES ES98931835T patent/ES2339308T3/es not_active Expired - Lifetime
- 1998-07-09 PT PT98931835T patent/PT1007084E/pt unknown
- 1998-07-09 DE DE69841521T patent/DE69841521D1/de not_active Expired - Lifetime
- 1998-07-09 EP EP10184161A patent/EP2316477A1/en not_active Withdrawn
- 1998-07-09 DK DK98931835.7T patent/DK1007084T3/da active
- 1998-07-09 EP EP98931835A patent/EP1007084B1/en not_active Expired - Lifetime
- 1998-07-09 NZ NZ502080A patent/NZ502080A/en not_active IP Right Cessation
- 1998-07-09 KR KR1020007000181A patent/KR100680631B1/ko not_active IP Right Cessation
- 1998-07-09 EP EP10154395A patent/EP2196213A1/en not_active Withdrawn
- 1998-07-09 AU AU82001/98A patent/AU725562B2/en not_active Expired
- 1998-07-09 CA CA2294865A patent/CA2294865C/en not_active Expired - Lifetime
- 1998-07-09 DE DE201012000033 patent/DE122010000033I1/de active Pending
- 1998-07-09 PL PL338037A patent/PL200495B1/pl unknown
- 1998-07-09 KR KR1020067015504A patent/KR20060101554A/ko not_active Application Discontinuation
- 1998-09-07 ZA ZA986074A patent/ZA986074B/xx unknown
-
2005
- 2005-01-03 US US11/027,683 patent/US7534441B2/en not_active Expired - Fee Related
-
2009
- 2009-04-02 US US12/384,242 patent/US20090226484A1/en not_active Abandoned
- 2009-04-09 US US12/384,974 patent/US20090291098A1/en not_active Abandoned
- 2009-10-23 JP JP2009244560A patent/JP5231378B2/ja not_active Expired - Lifetime
-
2010
- 2010-04-13 CY CY20101100331T patent/CY1109968T1/el unknown
- 2010-07-07 CY CY2010013C patent/CY2010013I1/el unknown
- 2010-07-09 FR FR10C0035C patent/FR10C0035I2/fr active Active
- 2010-07-28 LU LU91711C patent/LU91711I2/fr unknown
- 2010-08-24 FR FR10C0040C patent/FR10C0040I1/fr active Active
-
2011
- 2011-06-23 US US13/167,438 patent/US20110293647A1/en not_active Abandoned
-
2012
- 2012-08-16 US US13/587,249 patent/US8741303B2/en not_active Expired - Fee Related
- 2012-09-05 JP JP2012195610A patent/JP2013006862A/ja active Pending
-
2014
- 2014-04-18 US US14/256,043 patent/US20140271695A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR10C0035I2 (fr) | Composition immunogene de lh-rh et procedes concernant cette composition | |
| MX9703868A (es) | Inhibidores de cgmp-pde para el tratamiento de disfuncion erectil. | |
| AU4673099A (en) | Use of bioadhesives and adjuvants for the mucosal delivery of antigens | |
| HK1059562A1 (en) | Novel trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of csbp/p38 kinase mediated diseases | |
| WO2001079458A3 (en) | Polypeptides having haloperoxidase activity | |
| WO1996017523A3 (en) | Process for manufacture of reduced fat chocolate | |
| BG101139A (en) | Heteroatoms-containing cyclopentanopyridyloxazolidinons | |
| WO2001053463A3 (en) | COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES | |
| TW200603746A (en) | Iron sulfate based phosphate adsorbent | |
| HUT40331A (en) | Process for preparing pharmaceutical compositions containing a combination of dihidro-pyridines and ace-inhibitors | |
| AU6838501A (en) | Enzyme-catalyzed polyamides and compositions and processes of preparing and using the same | |
| IL120202A (en) | Container with freeze-dried vaccine components | |
| BG106008A (en) | Novel lhrh antagonists with improved solubility characteristics | |
| WO2000053231A3 (en) | Fatty acid-anticancer conjugates and uses thereof | |
| CA2348836A1 (en) | Feed for livestock | |
| CA2419471A1 (en) | Use of triazinetrione sulphones for controlling coccidioses | |
| BG100248A (en) | Squalene synthetase inhibitors | |
| TW277050B (xx) | ||
| GR3006671T3 (xx) | ||
| EP1284102A4 (en) | SYRUP-CONTAINING COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | |
| SI1106666T1 (en) | Powder composition and method for polishing stone | |
| AU6601000A (en) | 3-oxopropane-1-sulphonic acids and sulphonates | |
| MY108690A (en) | Mildewproofing agent for timber | |
| BG103087A (en) | Method for the preparation of naphthiridons and intermediate compounds | |
| WO2001046262A3 (en) | Olfactory receptor genes and pseudogenes in primates and mouse |